High expression of CD86 was significantly correlated to higher abundances of various immune cells, including two major types, cells that executed anti-tumor reactivity: activated CD4+ T cells, activated CD8+ T cells and cells that delivered pro-tumor suppression: macrophages, myeloid-derived suppressor cells (MDSCs), and regulatory T cells. The gene discussed is CD86; the disease is neoplasm.